Jounce Therapeutics Inc. (JNCE)
NASDAQ: JNCE
· Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM
Jounce Therapeutics Revenue
Jounce Therapeutics reported an annual revenue of $82M, reflecting a 204.75% growth. For the quarter ending December 31, 2022, Jounce Therapeutics generated $82M in revenue.
Revenue (ttm)
82M
Revenue Growth
204.75%
Price / Sales Ratio
0.7
Revenue / Employee
581.56K
Employees
141
Market Cap
98.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|